A core facility for advanced immune profiling techniques.
HIPC U19 Adaptive Immunophenotyping Core
['FUNDING_OTHER'] · BENAROYA RESEARCH INST AT VIRGINIA MASON · NIH-11295554
This study is all about using new techniques to take a closer look at your immune system, helping doctors understand how it works in different health conditions, so they can create better tests and personalized treatments just for you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BENAROYA RESEARCH INST AT VIRGINIA MASON (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-11295554 on ClinicalTrials.gov |
What this research studies
This research focuses on developing and providing advanced immunophenotyping techniques to better understand immune responses. By utilizing cutting-edge technologies, the project aims to analyze immune cell populations and their functions in various health conditions. Patients may benefit from improved diagnostic tools and personalized treatment strategies based on their immune profiles.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with immune-related conditions or those seeking personalized treatment options based on their immune system characteristics.
Not a fit: Patients without immune-related conditions or those not interested in immune profiling may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate immune profiling, enhancing personalized medicine approaches for patients.
How similar studies have performed: Similar research in immune profiling has shown promise in improving patient outcomes, indicating a potential for success in this approach.
Where this research is happening
SEATTLE, UNITED STATES
- BENAROYA RESEARCH INST AT VIRGINIA MASON — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WAMBRE, ERIK — BENAROYA RESEARCH INST AT VIRGINIA MASON
- Study coordinator: WAMBRE, ERIK
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.